chr8-102218827-A-C
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PP3_StrongPP5_Very_Strong
The NM_015713.5(RRM2B):c.671T>G(p.Ile224Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,612,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015713.5 missense
Scores
Clinical Significance
Conservation
Publications
- mitochondrial DNA depletion syndrome 8aInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal dominant progressive external ophthalmoplegiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Kearns-Sayre syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial neurogastrointestinal encephalomyopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RRM2B | NM_015713.5 | c.671T>G | p.Ile224Ser | missense_variant | Exon 6 of 9 | ENST00000251810.8 | NP_056528.2 | |
RRM2B | NM_001172477.1 | c.887T>G | p.Ile296Ser | missense_variant | Exon 6 of 9 | NP_001165948.1 | ||
RRM2B | NM_001172478.2 | c.515T>G | p.Ile172Ser | missense_variant | Exon 5 of 8 | NP_001165949.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152056Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251124 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1460400Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 726646 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74258 show subpopulations
ClinVar
Submissions by phenotype
RRM2B-related mitochondrial disease Pathogenic:1Other:2
RRM2B c.671T>G, p.(Ile224Ser), is a missense variant that changes a single amino acid from a highly conserved isoleucine to a serine. This is a rare variant present at an allele frequency of 0.0026% (4/152,056 alleles) in the gnomADv3.1 population database and reported as pathogenic/likely pathogenic by several clinical laboratories in the ClinVar database. In addition, multiple in silico models predict that the variant has a damaging effect on the protein. The RRM2B c.671T>G variant has previously been reported in an individual with late-onset PEO at 48 years, proximal muscle weakness, cataracts, and migraine (PMID: 23107649). The variant has also been reported as homozygous or in trans with another pathogenic variant in at least two individuals with neonatal-onset autosomal recessive MDMDs (PMID: 18504129, PMID: 30049826). Based on the available information, we consider this variant likely pathogenic. ACMG codes: PM2_Supporting (rare in gnomAD), PM3 (detected in trans with a pathogenic variant), PP3_Strong (REVEL score >= 0.932). -
- -
Variant interpreted as Pathogenic and reported on 05-12-2016 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
not provided Pathogenic:2
This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 224 of the RRM2B protein (p.Ile224Ser). This variant is present in population databases (rs515726196, gnomAD 0.004%). This missense change has been observed in individuals with autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions and autosomal recessive mitochondrial DNA depletion syndrome (PMID: 18504129, 23107649, 31462754; Invitae). ClinVar contains an entry for this variant (Variation ID: 132122). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RRM2B protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30049826, 24741716, 18504129, 23107649) -
Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction;C2749861:Mitochondrial DNA depletion syndrome 8a;C2751319:Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 Pathogenic:1
- -
Mitochondrial DNA depletion syndrome 8a Pathogenic:1
- -
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 Pathogenic:1
The highest population allele frequency in gnomAD v4.0 is 0.00003127 (0.003%; 2/63966 alleles in the European/Finnish population). PP3_Strong: Revel score is 0.987. PP1 Not Met: 1 informative meiosis in 1 family (clinical testing). PS4_Moderate: 5 unrelated probands with consistent phenotype for disorder (PMID:23107649, PMID:24086434). Sequencing funded by the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD): https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at